Abpro Holdings Inc (ABP)

$0.32 -0.01 (-3.93%)
Market Cap 16.61M
Revenue (ttm) 180,000.00
Net Income (ttm) -7.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,016.67%
Debt to Equity Ratio 0.00
Volume 361,000
Avg Vol 125,534
Day's Range N/A - N/A
Shares Out 52.22M
Stochastic %K 68%
Beta -0.07
Analysts Strong Sell
Price Target $2.00

Latest News on ABP

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 4 weeks ago

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Abpro Statement on the Departure of Former CEO Ian Chan

Mar 10, 2025, 6:34 PM EDT - 6 weeks ago

Abpro Statement on the Departure of Former CEO Ian Chan

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Dec 12, 2024, 4:05 PM EST - 4 months ago

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing